215 related articles for article (PubMed ID: 24526454)
1. Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2014 Mar; 52(3):313-22. PubMed ID: 24526454
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
3. Low-frequency ultrasound irradiation increases blood-tumor barrier permeability by transcellular pathway in a rat glioma model.
Xia CY; Liu YH; Wang P; Xue YX
J Mol Neurosci; 2012 Sep; 48(1):281-90. PubMed ID: 22528460
[TBL] [Abstract][Full Text] [Related]
4. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
[TBL] [Abstract][Full Text] [Related]
5. Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Liu J; Yao YL; Ma J
J Mol Neurosci; 2015 Sep; 57(1):11-20. PubMed ID: 26087743
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor increases permeability of the blood-tumor barrier via caveolae-mediated transcellular pathway.
Zhao LN; Yang ZH; Liu YH; Ying HQ; Zhang H; Xue YX
J Mol Neurosci; 2011 Jun; 44(2):122-9. PubMed ID: 21193965
[TBL] [Abstract][Full Text] [Related]
7. Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Yao YL; Ma J
J Mol Neurosci; 2015 Sep; 57(1):1-10. PubMed ID: 26044663
[TBL] [Abstract][Full Text] [Related]
8. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB.
Xie H; Xue YX; Liu LB; Liu YH; Wang P
J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039
[TBL] [Abstract][Full Text] [Related]
10. Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier.
Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB
J Mol Neurosci; 2015 May; 56(1):60-9. PubMed ID: 25416651
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway.
Liu LB; Xue YX; Liu YH
J Neurooncol; 2010 Sep; 99(2):187-94. PubMed ID: 20146088
[TBL] [Abstract][Full Text] [Related]
12. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z
FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792
[TBL] [Abstract][Full Text] [Related]
13. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.
Xia CY; Zhang Z; Xue YX; Wang P; Liu YH
J Neurooncol; 2009 Aug; 94(1):41-50. PubMed ID: 19234812
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Xie H
J Mol Neurosci; 2012 Jun; 47(2):408-17. PubMed ID: 21969114
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate-triggered ROS generation promotes caveolae-mediated transcytosis via Rac1 signaling and c-Src-dependent caveolin-1 phosphorylation in human brain endothelial cells.
Coelho-Santos V; Socodato R; Portugal C; Leitão RA; Rito M; Barbosa M; Couraud PO; Romero IA; Weksler B; Minshall RD; Fontes-Ribeiro C; Summavielle T; Relvas JB; Silva AP
Cell Mol Life Sci; 2016 Dec; 73(24):4701-4716. PubMed ID: 27376435
[TBL] [Abstract][Full Text] [Related]
17. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
18. Permeability of the blood-tumor barrier is enhanced by combining vascular endothelial growth factor with papaverine.
Yang ZH; Liu LB; Zhao LN; Liu YH; Xue YX
J Neurosci Res; 2014 Jun; 92(6):703-13. PubMed ID: 24523141
[TBL] [Abstract][Full Text] [Related]
19. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Xie H; Liu LB
J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144
[TBL] [Abstract][Full Text] [Related]
20. A potential role for caveolin-1 in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and Src.
Wu T; Zhang B; Ye F; Xiao Z
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F820-30. PubMed ID: 23269647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
